NCT01946386 - A Vasoconstriction Study With LEO 90100 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions

Psoriasis Vulgaris

Interventions

DRUG

LEO 90100 Aerosol, foam

The products will be applied on 6 test sites (according to random assignment to specific test sites predetermined on their anterior face of forearms) for 6 hours

DRUG

Betamethasone dipropionate in LEO 90100 Aerosol, foam, vehicle

DRUG

LEO 90100 Aerosol, foam, vehicle

DRUG

Daivobet® ointment

DRUG

Dermovate® cream

DRUG

Synalar® ointment

Trial Locations (1)

06202

CPCAD, Centre de Pharmacologie Clinique Appliquée à la Dermatologie, Nice